Home > Insider Trading > Filing (0000899243-22-029489)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1776197	Akumin Inc.	AKU	Services-Medical Laboratories (8071)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1901077	Murray Lee	C/O Akumin Inc. 8300 W. Sunrise Boulevard Plantation FL 33322		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2022-08-18	2,519	$1.10	304,511	No	4	P	Direct
Common Stock	Acquisiton	2022-08-18	6,982	$1.12	311,493	No	4	P	Direct
Common Stock	Acquisiton	2022-08-18	1,505	$1.11	312,998	No	4	P	Direct
Common Stock	Acquisiton	2022-08-18	453	$1.13	313,451	No	4	P	Direct
Common Stock	Acquisiton	2022-08-18	13,141	$1.15	326,592	No	4	P	Direct
Common Stock	Acquisiton	2022-08-18	400	$1.14	326,992	No	4	P	Direct
Common Stock	Acquisiton	2022-08-18	1,000	$1.43	5,500	No	4	P	Indirect	As trustee

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Indirect	As trustee

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Stock Option (right to buy)	$3.74	2019-11-16	2025-11-16	50,000	50,000	Direct
Common Stock	Stock Option (right to buy)	$3.29	2020-11-18	2026-11-18	52,213	52,213	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2025-11-16	50,000	50,000	Direct
2026-11-18	52,213	52,213	Direct

Footnotes

Represents shares of Common Stock held by trusts for the benefit of the Reporting Person's family, of which the Reporting Person is a trustee. The Reporting Person has sole voting and dispositive power with respect to such shares of Common Stock. The Reporting Person disclaims any pecuniary interest in such shares of Common Stock.
The Reporting Person was granted 50,000 Stock Options on November 16, 2018 under the Company's Amended and Restated Stock Option Plan (the "Option Plan"). One-hundred percent of the Stock Options have vested.
The Reporting Person was granted 52,213 Stock Options on November 18, 2019 under the Option Plan. Sixty-seven percent of the Stock Options have vested. The remaining 33% will vest on November 18, 2022.